Find Your Ideal Partner Faster: Advanced Search.

Unlock Strategic Partnerships in Pharma, Biotech & Medtech. 

Find Companies Offering or Seeking Collaborations, Services, Products & Technologies.

Save This Search | View as Grid | Order by Recently Added | Order by Company Name

 

Camena

 

The Science Village, Chesterford Research Park, Cambridge, United Kingdom

 

We are DNA designers at the forefront of DNA synthesis technology.

 

Our goal is to enable development of the next-generation of therapeutics and synthetic biology applications.

 

 

• Licencing Out
  We offer our products to other companies on an 'out-licensing' basis.
• Research and Development
  We offer co-development opportunities.

 

Partner Profile

 

 

HekaBio

 

Chikiriya Tokyo Bldg. 8F 1-9-15 Nihonbashimuromachi, Chuo-ku, Tokyo, 103-0022, Japan

 

We are advancing a portfolio of highly-anticipated innovations

 

HekaBio is an asset-light emerging commercial-stage biopharma and MedTech platform for in-licensing early, de-risked assets to commercialize in Japan and the APAC region.

 

 

• Licencing In
  We are looking for products from other companies to 'in-license'.

 

Partner Profile

 

 

Antengene Corp

 

Suite 704,, 999 West Zhongshan Road, Shanghai, China

 

Antengene has developed AnTenGager™ TCE 2.0, a proprietary T cell engager (TCE) technology platform

 

Leveraging our internal research and development capabilities, Antengene has developed AnTenGager™ TCE 2.0, a proprietary T cell engager (TCE) technology platform with steric hindrance-masking technology that offers enhanced anti-tumor activity with reduced risk of cytokine release syndrome (CRS).

 

 

• Licencing Out
  We offer our products to other companies on an 'out-licensing' basis.
• Research and Development
  We offer co-development opportunities.

 

Partner Profile

 

 

Dermaliq Therapeutics

 

1201 North Market Street,, Suite 111,, Wilmington, DE 19801, USA

 

The evolutionary hyliQ®– technology-to provide cutaneous drug delivery with unmatched bioavailability of pharmaceutical actives.

 

Our goal is to establish a comprehensive pipeline of next-generation topical drugs and medical skin care products based on our proprietary hyliQ® technology.

 

 

• Licencing Out
  We offer our products to other companies on an 'out-licensing' basis.
• Research and Development
  We offer co-development opportunities.

 

Partner Profile

 

 

Spyglass Pharma

 

27061 Aliso Creek Rd, Suite 100, Aliso Viejo, CA 92656, USA

 

The first and only controlled release drug delivery platform for all cataract surgeons

 

The SpyGlass Pharma™ Drug Delivery Platform is implanted with the SpyGlass IOL into the capsular bag via standard cataract surgical technique

 

 

• Licencing Out
  We offer our products to other companies on an 'out-licensing' basis.
• Research and Development
  We offer co-development opportunities.

 

Partner Profile

 

 

Vaccinex

 

Rochester, New York, USA

 

ActivMab® Discovery Solutions

 

ActivMab® platform enables the discovery and development of antibodies with high selectivity and novel mechanisms of action against complex membrane proteins.

 

 

• Licencing Out
  We offer our products to other companies on an 'out-licensing' basis.
• Research and Development
  We offer co-development opportunities.

 

Partner Profile

 

 

BioSurfaces

 

200 Homer Ave, Ashland, Massachusetts, MA 01721, USA

 

Electrospinning- A Simple Breakdown of Our Core Technology

 

Electrospinning is a technique that uses high voltage to deposit polymer nanofibers onto a surface from a liquid polymer solution. By using collection surfaces of various shapes and sizes as molds, this process can create standalone nanofibrous materials or coat nanofibers onto existing devices and material

 

 

• Licencing Out
  We offer our products to other companies on an 'out-licensing' basis.
• Research and Development
  We offer co-development opportunities.

 

Partner Profile

 

 

BioVaxys Technology

 

146 Thirtieth Street Suite 100, Etobicoke, Ontario, Canada

 

DPX™ a Lipid Based Delivery Platform for Vaccines and other Bioactives

 

Acquired from IMV Inc., the DPX™ platform is a cutting-edge lipid-based delivery system. It's designed for encapsulating a diverse array of bioactive molecules, leading to enhanced and sustained immune responses.

 

Partner Profile

 

 

Partnerships in the Pharmaceutical and Medical Device Sectors

Partnership activity between innovators and pharmaceutical service providers are now mainstream activities within our hi-tech industry. This can decrease product development times, bringing products to market quicker while reducing cost.

Our platform provides customised search capabilities to quickly identify activities in the area of pharma technology, relationship type, pharmaceutical form, therapeutic application or drug delivery innovations.

Our partnership data is integrated with our software applications allowing you to quickly identify a suitable partner and qualify and initiate either a development project or supply agreement.

Take the Next Step

We update the partnership's data daily. If you would like to add your company to the platform, you can do so for free ...
Register for an account to add your licensing and partnership details »

Should you have any questions or require further information please contact us ...
Contact the support team »

Check if your company is listed and claim your online profile ...
Search for your company listing »